EPIDERMAL GROWTH FACTOR RECEPTOR
MUTATION STATUS: DOES YOUNGER
MEAN MORE FREQUENTLY MUTATED?
Wójcik P1, Krawczyk P2, Chorostowska-Wynimko J3, Reszka K4, Duk K3, Muszczyńska-Bernhard B5,
Pankowski J6, Wojas-Krawczyk K2, Czyżewicz G7, Ramlau R8, Skoczek M7, Grenda A2,*,
Orłowski T3, Grodzki T9, Piwowar M10, Roszkowski-Śliż K3, Milanowski J2
*Corresponding Author: Anna Grenda, Ph.D., Department of Pneumonology, Oncology and Allergology, Medical University
of Lublin, Jaczewskiego 8, 20-954 Lublin, Poland. Tel./Fax: +48-81-724-42-93. E-mail: an.grenda@gmail.com
page: 89
|
|
REFERENCES
1. Mok T, Wu YL, Thongprasert S, Yang CH, Chu DT,
Saijo N, et al. Gefitinib or carboplatin-paclitaxel in
pulmonary adenocarcinoma. N Engl J Med. 2009;
361(10); 947-957.
2. Nagashima O, Ohashi R, Yoshioka Y, Inagaki A, Tajima
M Koinuma Y, et al. High prevalence of gene
abnormalities in young patients with lung cancer. J
Thorac Dis. 2013; 5(1): 27-30.
3. Van den Bussche CJ, Illei PB, Lin MT, Ettinger DS,
Maleki Z. Molecular alterations in non-small cell lung
carcinoma of the young. Hum Pathol. 2014; 45(12):
2379-2387.
4. Sacher AG, Dahlberg SE, Heng J, Mach S, Jänne PA,
Oxnard GR. Lung cancer diagnosed in the young is
associated with enrichment for targetable genomic
alterations and poor prognosis. JAMA Oncol. 2016;
2(3): 313-320.
5. Nishi T, Yokose T, Miyagi Y, Daigo Y, Ito H, Isaka
T, et al. Clinicopathological features and EGFR gene
mutation status in elderly patients with resected nonsmall-
cell lung cancer. BMC Cancer. 2014; 14: 610.
doi: 10.1186/ 1471-2407-14-610.
6. Shi Y, Au JS, Thongprasert S, Srinivasan S, Tsai CM,
Khoa MT, et al. A prospective, molecular epidemiology
study of EGFR mutations in Asian patients with
advanced non-small-cell lung cancer of adenocarcinoma
histology (PIONEER). J Thorac Oncol. 2014;
9(2): 154-162.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
